Genetic alterations detected by comparative genomic hybridization in BRCAX breast and ovarian cancers of Brazilian population
Metrics: PDF 1183 views | HTML 2971 views | ?
Paula Silva Felicio1, Lucas Tadeu Bidinotto1,2, Matias Eliseo Melendez1, Rebeca Silveira Grasel1, Natalia Campacci1, Henrique C.R. Galvão3, Cristovam Scapulatempo-Neto4, Rozany Mucha Dufloth4, Adriane Feijó Evangelista1 and Edenir Inêz Palmero1,2
1Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, SP, Brazil
2Barretos School of Health Sciences-FACISB, Barretos, SP, Brazil
3Department of Oncogenetics, Barretos Cancer Hospital, Barretos, SP, Brazil
4Department of Pathology, Barretos Cancer Hospital, Barretos, SP, Brazil
Edenir Inêz Palmero, email: [email protected]
Keywords: BRCAX; hereditary breast cancer; hereditary breast and ovarian cancer predisposition syndrome; CNV alterations
Received: August 09, 2017 Accepted: May 14, 2018 Published: June 08, 2018
Background: About 5–10% of breast/ovarian cancers are hereditary. However, for a large proportion of cases (around 50%), the genetic cause remains unknown. These cases are grouped in a separated BRCAX category. The aim of this study was to identify genomic alterations in BRCA1/BRCA2 wild-type tumor samples from women with family history strongly suggestive of hereditary breast/ovarian cancer.
Results: A cohort of 31 Brazilian women was included in the study. Using the GISTIC algorithm, we identified 20 regions with genomic gains and 31 with losses. The most frequent altered regions were 1q21.2, 6p22.1 and 8p23.3 in breast tumors and Xq26 and Xp22.32-22.31 among the ovarian cancer cases. An interesting association identified was the loss of 22q13.31-13.32 and the presence of ovarian cancer cases. Among the genes present in the frequently altered regions, we found FGFR1, NSMCE2, CTTN, CRLF2, ERBB2, STARD3, MIR3201 and several genes of RAET and ULBP family.
Conclusions: In conclusion, our results suggest that alterations on chromosomes 1, 6, 8 and X are common on BRCAX tumors and that the loss on 22q can be associated with the presence of ovarian cancer.
Methods: DNA copy number alterations were analyzed by 60K array comparative genomic hybridization in breast and ovarian FFPE tumors.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.